Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment

American Psychiatric Association: Diagnostic criteria from DSM-IV-TR. 2000, Washington, D.C: American Psychiatric Association Cryan JF, Sweeney FF: The age of anxiety: role of animal models of anxiolytic action in drug discovery. Br J Pharmacol. 2011, 164: 1129-1161. 10.1111/j.1476-5381.2011.01362.x. Durant C, Christmas D, Nutt D: The pharmacology of anxiety. Curr Top Behav Neurosci. 2010, 2: 303-330. Jacobson LH, Cryan JF: Genetic approaches to modeling anxiety in animals. Curr Top Behav Neurosci. 2010, 2: 161-201. Westenberg HG: Recent advances in understanding and treating social anxiety disorder. CNS Spectr. 2009, 14: 24-33. Pinna G, Costa E, Guidotti A: Fluoxetine and norfluoxetine stereospecifically facilitate pentobarbital sedation by increasing neurosteroids. Proc Natl Acad Sci USA. 2004, 101: 6222-6225. 10.1073/pnas.0401479101. Wong DT, Bymaster FP, Engleman EA: Prozac (fluoxetine, lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: Twenty years since its first publication. Life Sci. 1995, 57: 411-441. 10.1016/0024-3205(95)00209-O. Wong DT, Bymaster FP, Reid LR, Fuller RW, Perry KW: Inhibition of serotonin uptake by optical isomers of fluoxetine. Drug Dev Res. 1985, 6: 397-403. 10.1002/ddr.430060412. Koch S, Perry KW, Nelson DL, Conway RG, Threlkeld PG, Bymaster FP: R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study. Neuropsychopharmacology. 2002, 27: 949-959. 10.1016/S0893-133X(02)00377-9. Robertson DW, Krushinski JH, Fuller RW, Leander JD: Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor. J Med Chem. 1988, 31: 1412-1417. 10.1021/jm00402a027. Egan RJ, Bergner CL, Hart PC, Cachat JM, Canavello PR, Elegante MF, Elkhayat SI, Bartels BK, Tien AK, Tien DH: Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish. Behav Brain Res. 2009, 205: 38-44. 10.1016/j.bbr.2009.06.022. Dulawa SC, Holick KA, Gundersen B, Hen R: Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression. Neuropsychopharmacology. 2004, 29: 1321-1330. 10.1038/sj.npp.1300433. Pinna G, Costa E, Guidotti A: SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake. Curr Opin Pharmacol. 2009, 9: 24-30. 10.1016/j.coph.2008.12.006. Pinna G, Costa E, Guidotti A: Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology (Berl). 2006, 186: 362-372. 10.1007/s00213-005-0213-2. Longone P, Di Michele F, D'Agati E, Romeo E, Pasini A, Rupprecht R: Neurosteroids as neuromodulators in the treatment of anxiety disorders. Front Endocrinol (Lausanne). 2011, 2: 55- Barbaccia ML: Neurosteroidogenesis: relevance to neurosteroid actions in brain and modulation by psychotropic drugs. Crit Rev Neurobiol. 2004, 16: 67-74. 10.1615/CritRevNeurobiol.v16.i12.70. Reddy DS, O'Malley BW, Rogawski MA: Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology. 2005, 48: 14-24. 10.1016/j.neuropharm.2004.09.002. Pinna G, Rasmusson AM: Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder. J Neuroendocrinol. 2012, 24: 102-116. 10.1111/j.1365-2826.2011.02234.x. Schule C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, Rupprecht R: Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs?. Neuroscience. 2011, 191: 55-77. Guidotti A, Dong E, Matsumoto K, Pinna G, Rasmusson AM, Costa E: The socially-isolated mouse: a model to study the putative role of allopregnanolone and 5α-dihydroprogesterone in psychiatric disorders. Brain Res Rev. 2001, 37: 110-115. 10.1016/S0165-0173(01)00129-1. Pinna G, Dong E, Matsumoto K, Costa E, Guidotti A: In socially isolated mice, the reversal of brain allopregnanolone down-regulation mediates the anti-aggressive action of fluoxetine. Proc Natl Acad Sci USA. 2003, 100: 2035-2040. 10.1073/pnas.0337642100. Jain NS, Hirani K, Chopde CT: Reversal of caffeine-induced anxiety by neurosteroid 3-alpha-hydroxy-5-alpha-pregnane-20-one in rats. Neuropharmacology. 2005, 48: 627-638. 10.1016/j.neuropharm.2004.11.016. Bitran D, Foley M, Audette D, Leslie N, Frye CA: Activation of peripheral mitochondrial benzodiazepine receptors in the hippocampus stimulates allopregnanolone synthesis and produces anxiolytic-like effects in the rat. Psychopharmacology (Berl). 2000, 151: 64-71. 10.1007/s002130000471. Landgraf R: Neuropeptides in anxiety modulation. Handb Exp Pharmacol. 2005, 169: 335-369. 10.1007/3-540-28082-0_12. Semsar K, Perreault HA, Godwin J: Fluoxetine-treated male wrasses exhibit low AVT expression. Brain Res. 2004, 1029: 141-147. 10.1016/j.brainres.2004.09.030. Cryan JF, Holmes A: The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov. 2005, 4: 775-790. 10.1038/nrd1825. Overli O, Pottinger TG, Carrick TR, Overli E, Winberg S: Differences in behaviour between rainbow trout selected for high- and low-stress responsiveness. J Exp Biol. 2002, 205: 391-395. Landgraf R, Wigger A: High vs low anxiety-related behavior rats: an animal model of extremes in trait anxiety. Behav Genet. 2002, 32: 301-314. 10.1023/A:1020258104318. Wong RY, Perrin F, Oxendine SE, Kezios ZD, Sawyer S, Zhou L, Dereje S, Godwin J: Comparing behavioral responses across multiple assays of stress and anxiety in zebrafish (Danio rerio). Behaviour. 2012, 149: 1205-1240. 10.1163/1568539X-00003018. Maximino C, de Brito TM, da Silva Batista AW, Herculano AM, Morato S, Gouveia A: Measuring anxiety in zebrafish: a critical review. Behav Brain Res. 2010, 214: 157-171. 10.1016/j.bbr.2010.05.031. Stewart A, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff AV: Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology. 2012, 62: 135-143. 10.1016/j.neuropharm.2011.07.037. Clark KJ, Boczek NJ, Ekker SC: Stressing zebrafish for behavioral genetics. Rev Neurosci. 2011, 22: 49-62. Steenbergen PJ, Richardson MK, Champagne DL: The use of the zebrafish model in stress research. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 1432-1451. 10.1016/j.pnpbp.2010.10.010. Champagne DL, Hoefnagels CC, de Kloet RE, Richardson MK: Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research. Behav Brain Res. 2010, 214: 332-342. 10.1016/j.bbr.2010.06.001. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L: The zebrafish reference genome sequence and its relationship to the human genome. Nature. 2013, 496: 498-503. 10.1038/nature12111. Griebel G, Belzung C, Perrault G, Sanger DJ: Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl). 2000, 148: 164-170. 10.1007/s002130050038. Miller BH, Schultz LE, Gulati A, Su AI, Pletcher MT: Phenotypic Characterization of a Genetically Diverse Panel of Mice for Behavioral Despair and Anxiety. PLoS One. 2010, 5: e14458-10.1371/journal.pone.0014458. Panula P, Chen YC, Priyadarshini M, Kudo H, Semenova S, Sundvik M, Sallinen V: The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis. 2010, 40: 46-57. 10.1016/j.nbd.2010.05.010. Lillesaar C: The serotonergic system in fish. J Chem Neuroanat. 2011, 41: 294-308. 10.1016/j.jchemneu.2011.05.009. Wang Y, Takai R, Yoshioka H, Shirabe K: Characterization and expression of serotonin transporter genes in zebrafish. Tohoku J Exp Med. 2006, 208: 267-274. 10.1620/tjem.208.267. Gould GG, Brooks BW: Frazer A: [(3)H] citalopram binding to serotonin transporter sites in minnow brains. Basic Clin Pharmacol Toxicol. 2007, 101: 203-210. 10.1111/j.1742-7843.2007.00100.x. Park JW, Heah TP, Gouffon JS, Henry TB, Sayler GS: Global gene expression in larval zebrafish (Danio rerio) exposed to selective serotonin reuptake inhibitors (fluoxetine and sertraline) reveals unique expression profiles and potential biomarkers of exposure. Environ Pollut. 2012, 167: 163-170. Zon LI, Peterson RT: In vivo drug discovery in the zebrafish. Nat Rev Drug Discov. 2005, 4: 35-44. 10.1038/nrd1606. Rihel J, Schier AF: Behavioral screening for neuroactive drugs in zebrafish. Dev Neurobiol. 2012, 72: 373-385. 10.1002/dneu.20910. Grunwald DJ, Eisen JS: Headwaters of the zebrafish – emergence of a new model vertebrate. Nat Rev Genet. 2002, 3: 717-724. Brooks BW, Chambliss CK, Stanley JK, Ramirez A, Banks KE, Johnson RD, Lewis RJ: Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem. 2005, 24: 464-469. 10.1897/04-081R.1. Gaworecki KM, Klaine SJ: Behavioral and biochemical responses of hybrid striped bass during and after fluoxetine exposure. Aquat Toxicol. 2008, 88: 207-213. 10.1016/j.aquatox.2008.04.011. Paterson G, Metcalfe CD: Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes). Chemosphere. 2008, 74: 125-130. 10.1016/j.chemosphere.2008.08.022. Auer PL, Doerge RW: Statistical design and analysis of RNA sequencing data. Genetics. 2010, 185: 405-416. 10.1534/genetics.110.114983. Wu TD, Nacu S: Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics. 2010, 26: 873-881. 10.1093/bioinformatics/btq057. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L: Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protocols. 2012, 7: 562-578. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, Salzberg SL, Wold BJ, Pachter L: Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotech. 2010, 28: 511-515. 10.1038/nbt.1621. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L: Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotech. 2013, 31: 46-53. Reimand J, Arak T, Vilo J g: Profiler–a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res. 2011, 39: W307-W315. 10.1093/nar/gkr378. Reimand J, Kull M, Peterson H, Hansen J, Vilo J g: Profiler–a web-based toolset for functional profiling of gene lists from large-scale experiments. Nucleic Acids Res. 2007, 35: W193-W200. 10.1093/nar/gkm226. Cummings ME, Larkins-Ford J, Reilly CR, Wong RY, Ramsey M, Hofmann HA: Sexual and social stimuli elicit rapid and contrasting genomic responses. Proc Biol Sci. 2008, 275: 393-402. 10.1098/rspb.2007.1454. Lynch KS, Ramsey ME, Cummings ME: The mate choice brain: comparing gene profiles between female choice and male coercive poeciliids. Genes Brain Behav. 2012, 11: 222-229. 10.1111/j.1601-183X.2011.00742.x. Ramsey ME, Maginnis TL, Wong RY, Brock C, Cummings ME: Identifying context-specific gene profiles of social, reproductive, and mate preference behavior in a fish species with female mate choice. Front Neurosci. 2012, 6: 62- Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002, 30: e36-10.1093/nar/30.9.e36. McCurley AT, Callard GV: Characterization of housekeeping genes in zebrafish: male-female differences and effects of tissue type, developmental stage and chemical treatment. BMC Mol Biol. 2008, 9: 102-10.1186/1471-2199-9-102. Sousa N, Almeida OF, Wotjak CT: A hitchhiker’s guide to behavioral analysis in laboratory rodents. Genes Brain Behav. 2006, 5 (Suppl 2): 5-24. Uzunova V, Sheline Y, Davis JM, Rasmusson A, Uzunov DP, Costa E, Guidotti A: Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc Natl Acad Sci USA. 1998, 95: 3239-3244. 10.1073/pnas.95.6.3239. Godwin J, Thompson R: Nonapeptides and social behavior in fishes. Horm Behav. 2012, 61: 230-238. 10.1016/j.yhbeh.2011.12.016. Braida D, Donzelli A, Martucci R, Capurro V, Busnelli M, Chini B, Sala M: Neurohypophyseal hormones manipulation modulate social and anxiety-related behavior in zebrafish. Psychopharmacology (Berl). 2012, 220: 319-330. 10.1007/s00213-011-2482-2. Thorsell A: Central neuropeptide Y in anxiety- and stress-related behavior and in ethanol intake. Ann N Y Acad Sci. 2008, 1148: 136-140. 10.1196/annals.1410.083. Neumann ID, Landgraf R: Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors. Trends Neurosci. 2012, 35: 649-659. 10.1016/j.tins.2012.08.004. Karlsson RM, Holmes A, Heilig M, Crawley JN: Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav. 2005, 80: 427-436. 10.1016/j.pbb.2004.12.009. Slattery DA, Neumann ID: Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology. 2010, 58: 56-61. 10.1016/j.neuropharm.2009.06.038. Kask A, Harro J, von Horsten S, Redrobe JP, Dumont Y, Quirion R: The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev. 2002, 26: 259-283. 10.1016/S0149-7634(01)00066-5. Missig G, Ayers LW, Schulkin J, Rosen JB: Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology. 2010, 35: 2607-2616. 10.1038/npp.2010.155. Trent NL, Menard JL: Infusions of neuropeptide Y into the lateral septum reduce anxiety-related behaviors in the rat. Pharmacol Biochem Behav. 2011, 99: 580-590. 10.1016/j.pbb.2011.06.009. Onaka T, Takayanagi Y, Yoshida M: Roles of oxytocin neurones in the control of stress, energy metabolism, and social behaviour. J Neuroendocrinol. 2012, 24: 587-598. 10.1111/j.1365-2826.2012.02300.x. Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M: Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011, 12: 524-538. 10.1038/nrn3044. Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, Stout JC, Nathan PJ: Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology. 2010, 35: 2403-2413. 10.1038/npp.2010.123. Petrovic P, Kalisch R, Singer T, Dolan RJ: Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci. 2008, 28: 6607-6615. 10.1523/JNEUROSCI.4572-07.2008. Donner J, Sipila T, Ripatti S, Kananen L, Chen X, Kendler KS, Lonnqvist J, Pirkola S, Hettema JM, Hovatta I: Support for involvement of glutamate decarboxylase 1 and neuropeptide Y in anxiety susceptibility. Am J Med Genet B Neuropsychiatr Genet. 2012, 159B: 316-327. 10.1002/ajmg.b.32029. Wendelaar Bonga SE: The stress response in fish. Physiol Rev. 1997, 77: 591-625. Barton BA: Stress in fishes: a diversity of responses with particular reference to changes in circulating corticosteroids. Integr Comp Biol. 2002, 42: 517-525. 10.1093/icb/42.3.517. Alsop D, Vijayan MM: Molecular programming of the corticosteroid stress axis during zebrafish development. Comp Biochem Physiol A Mol Integr Physiol. 2009, 153: 49-54. 10.1016/j.cbpa.2008.12.008. Fekete EM, Zorrilla EP: Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front Neuroendocrinol. 2007, 28: 1-27. 10.1016/j.yfrne.2006.09.002. Pan W, Kastin AJ: Urocortin and the brain. Prog Neurobiol. 2008, 84: 148-156. 10.1016/j.pneurobio.2007.10.008. Gysling K, Forray MI, Haeger P, Daza C, Rojas R: Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?. Brain Res Brain Res Rev. 2004, 47: 116-125. 10.1016/j.brainresrev.2004.06.001. Neufeld-Cohen A, Tsoory MM, Evans AK, Getselter D, Gil S, Lowry CA, Vale WW, Chen A: A triple urocortin knockout mouse model reveals an essential role for urocortins in stress recovery. Proc Natl Acad Sci USA. 2010, 107: 19020-19025. 10.1073/pnas.1013761107. Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF: Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat. Psychopharmacology (Berl). 2002, 160: 113-121. 10.1007/s00213-001-0940-y. Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer SL, Shaw J, Fitz SD, Sajdyk TJ: Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Eur J Pharmacol. 2005, 509: 145-153. 10.1016/j.ejphar.2004.12.030. Moreau JL, Kilpatrick G, Jenck F: Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport. 1997, 8: 1697-1701. 10.1097/00001756-199705060-00027. Slawecki CJ, Somes C, Rivier JE, Ehlers CL: Neurophysiological effects of intracerebroventricular administration of urocortin. Peptides. 1999, 20: 211-218. 10.1016/S0196-9781(98)00160-0. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A: Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res. 1999, 100: 207-215. 10.1016/S0166-4328(98)00132-6. Venihaki M, Sakihara S, Subramanian S, Dikkes P, Weninger SC, Liapakis G, Graf T, Majzoub JA: Urocortin III, a brain neuropeptide of the corticotropin-releasing hormone family: modulation by stress and attenuation of some anxiety-like behaviours. J Neuroendocrinol. 2004, 16: 411-422. 10.1111/j.1365-2826.2004.01170.x. Jamieson PM, Li C, Kukura C, Vaughan J, Vale W: Urocortin 3 modulates the neuroendocrine stress response and is regulated in rat amygdala and hypothalamus by stress and glucocorticoids. Endocrinology. 2006, 147: 4578-4588. 10.1210/en.2006-0545. Deussing JM, Breu J, Kuhne C, Kallnik M, Bunck M, Glasl L, Yen YC, Schmidt MV, Zurmuhlen R, Vogl AM: Urocortin 3 modulates social discrimination abilities via corticotropin-releasing hormone receptor type 2. J Neurosci. 2010, 30: 9103-9116. Lennartsson AK, Jonsdottir IH: Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology. 2011, 36: 1530-1539. 10.1016/j.psyneuen.2011.04.007. Diaz-Moran S, Palencia M, Mont-Cardona C, Canete T, Blazquez G, Martinez-Membrives E, Lopez-Aumatell R, Tobena A, Fernandez-Teruel A: Coping style and stress hormone responses in genetically heterogeneous rats: comparison with the Roman rat strains. Behav Brain Res. 2012, 228: 203-210. 10.1016/j.bbr.2011.12.002. Torner L, Neumann ID: The brain prolactin system: involvement in stress response adaptations in lactation. Stress. 2002, 5: 249-257. 10.1080/1025389021000048638. Pottinger TG, Prunet P, Pickering AD: The effects of confinement stress on circulating prolactin levels in rainbow trout (Oncorhynchus mykiss) in fresh water. Gen Comp Endocrinol. 1992, 88: 454-460. 10.1016/0016-6480(92)90240-K. Avella M, Schreck CB, Prunet P: Plasma prolactin and cortisol concentrations of stressed coho salmon, Oncorhynchus kisutch, in fresh water or salt water. Gen Comp Endocrinol. 1991, 81: 21-27. 10.1016/0016-6480(91)90121-L. Liu GX, Cai GQ, Cai YQ, Sheng ZJ, Jiang J, Mei Z, Wang ZG, Guo L, Fei J: Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1. Neuropsychopharmacology. 2007, 32: 1531-1539. 10.1038/sj.npp.1301281. Mennigen JA, Martyniuk CJ, Crump K, Xiong H, Zhao E, Popesku J, Anisman H, Cossins AR, Xia X, Trudeau VL: Effects of fluoxetine on the reproductive axis of female goldfish (Carassius auratus). Physiol Genomics. 2008, 35: 273-282. 10.1152/physiolgenomics.90263.2008. Benton CS, Miller BH, Skwerer S, Suzuki O, Schultz LE, Cameron MD, Marron JS, Pletcher MT, Wiltshire T: Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains. Psychopharmacology (Berl). 2012, 221: 297-315. 10.1007/s00213-011-2574-z. Huang GJ, Ben-David E, Tort Piella A, Edwards A, Flint J, Shifman S: Neurogenomic evidence for a shared mechanism of the antidepressant effects of exercise and chronic fluoxetine in mice. PLoS One. 2012, 7: e35901-10.1371/journal.pone.0035901. Lee JH, Ko E, Kim YE, Min JY, Liu J, Kim Y, Shin M, Hong M, Bae H: Gene expression profile analysis of genes in rat hippocampus from antidepressant treated rats using DNA microarray. BMC Neurosci. 2010, 11: 152-10.1186/1471-2202-11-152. Griffith M, Griffith OL, Mwenifumbo J, Goya R, Morrissy AS, Morin RD, Corbett R, Tang MJ, Hou YC, Pugh TJ: Alternative expression analysis by RNA sequencing. Nat Methods. 2010, 7: 843-847. 10.1038/nmeth.1503. Morey JS, Ryan JC, Van Dolah FM: Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol Proced Online. 2006, 8: 175-193. 10.1251/bpo126. Hawlena D, Schmitz OJ: Herbivore physiological response to predation risk and implications for ecosystem nutrient dynamics. Proc Natl Acad Sci USA. 2010, 107: 15503-15507. 10.1073/pnas.1009300107. Lima SL, Anders Pape Møller MM, Peter JBS: Stress and Decision Making under the Risk of Predation: Recent Developments from Behavioral, Reproductive, and Ecological Perspectives. Advances in the Study of Behavior. Volume, Volume 27. 1998, San Diego, CA USA: Academic Press Inc, 215-290. Santos EM, Kille P, Workman VL, Paull GC, Tyler CR: Sexually dimorphic gene expression in the brains of mature zebrafish. Comp Biochem Physiol A Mol Integr Physiol. 2008, 149: 314-324. 10.1016/j.cbpa.2008.01.010. Toth AL, Varala K, Newman TC, Miguez FE, Hutchison SK, Willoughby DA, Simons JF, Egholm M, Hunt JH, Hudson ME, Robinson GE: Wasp gene expression supports an evolutionary link between maternal behavior and eusociality. Science. 2007, 318: 441-444. 10.1126/science.1146647. Sen Sarma M, Whitfield CW, Robinson GE: Species differences in brain gene expression profiles associated with adult behavioral maturation in honey bees. BMC Genomics. 2007, 8: 202-10.1186/1471-2164-8-202. Whitfield CW, Cziko A-M, Robinson GE: Gene expression profiles in the brain predict behavior in individual honey bees. Science (Washington D C). 2003, 302: 296-299. 10.1126/science.1086807. Aubin-Horth N, Landry CR, Letcher BH, Hofmann HA: Alternative life histories shape brain gene expression profiles in males of the same population. Proc Biol Sci. 2005, 272: 1655-1662. 10.1098/rspb.2005.3125. Renn SC, Aubin-Horth N, Hofmann HA: Fish and chips: functional genomics of social plasticity in an African cichlid fish. J Exp Biol. 2008, 211: 3041-3056. 10.1242/jeb.018242. Sanogo YO, Hankison S, Band M, Obregon A, Bell AM: Brain transcriptomic response of threespine sticklebacks to cues of a predator. Brain Behav Evol. 2011, 77: 270-285. 10.1159/000328221. Catalan A, Hutter S, Parsch J: Population and sex differences in Drosophila melanogaster brain gene expression. BMC Genomics. 2012, 13: 654-10.1186/1471-2164-13-654. Drew RE, Settles ML, Churchill EJ, Williams SM, Balli S, Robison BD: Brain transcriptome variation among behaviorally distinct strains of zebrafish (Danio rerio). BMC Genomics. 2012, 13: 323-10.1186/1471-2164-13-323. Wong RY, Ramsey ME, Cummings ME: Localizing brain regions associated with female mate preference behavior in a swordtail. PLoS One. 2012, 7: e50355-10.1371/journal.pone.0050355. Fitzpatrick MJ, Ben-Shahar Y, Smid HM, Vet LEM, Robinson GE, Sokolowski MB: Candidate genes for behavioural ecology. Trends Ecol Evol. 2005, 20: 96-104. 10.1016/j.tree.2004.11.017. Wada K, Howard JT, McConnell P, Whitney O, Lints T, Rivas MV, Horita H, Patterson MA, White SA, Scharff C: A molecular neuroethological approach for identifying and characterizing a cascade of behaviorally regulated genes. Proc Natl Acad Sci USA. 2006, 103: 15212-15217. 10.1073/pnas.0607098103. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M: KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012, 40: D109-D114. 10.1093/nar/gkr988. Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093/nar/28.1.27. Mennigen JA, Lado WE, Zamora JM, Duarte-Guterman P, Langlois VS, Metcalfe CD, Chang JP, Moon TW, Trudeau VL: Waterborne fluoxetine disrupts the reproductive axis in sexually mature male goldfish, Carassius auratus. Aquat Toxicol. 2010, 100: 354-364. 10.1016/j.aquatox.2010.08.016. Gunn BG, Brown AR, Lambert JJ, Belelli D: Neurosteroids and GABA(A) Receptor Interactions: A Focus on Stress. Front Neurosci. 2011, 5: 131- Zimmerberg B, Brunelli SA, Hofer MA: Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone. Pharmacol Biochem Behav. 1994, 47: 735-738. 10.1016/0091-3057(94)90181-3. Akwa Y, Purdy RH, Koob GF, Britton KT: The amygdala mediates the anxiolytic-like effect of the neurosteroid allopregnanolone in rat. Behav Brain Res. 1999, 106: 119-125. 10.1016/S0166-4328(99)00101-1. Evans J, Sun Y, McGregor A, Connor B: Allopregnanolone regulates neurogenesis and depressive/anxiety-like behaviour in a social isolation rodent model of chronic stress. Neuropharmacology. 2012, 63: 1315-1326. 10.1016/j.neuropharm.2012.08.012. Engin E, Treit D: The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol. 2007, 18: 461-470. 10.1097/FBP.0b013e3282d28f6f. Homberg JR, Olivier JD, Blom T, Arentsen T, van Brunschot C, Schipper P, Korte-Bouws G, van Luijtelaar G, Reneman L: Fluoxetine exerts age-dependent effects on behavior and amygdala neuroplasticity in the rat. PLoS One. 2011, 6: e16646-10.1371/journal.pone.0016646. Bouet V, Klomp A, Freret T, Wylezinska-Arridge M, Lopez-Tremoleda J, Dauphin F, Boulouard M, Booij J, Gsell W, Reneman L: Age-dependent effects of chronic fluoxetine treatment on the serotonergic system one week following treatment. Psychopharmacology (Berl). 2012, 221: 329-339. 10.1007/s00213-011-2580-1. Olivier JD, Blom T, Arentsen T, Homberg JR: The age-dependent effects of selective serotonin reuptake inhibitors in humans and rodents: A review. Prog Neuropsychopharmacol Biol Psychiatry. 2011, 35: 1400-1408. 10.1016/j.pnpbp.2010.09.013.